BALVERZA (erdafitinib), 3, 4, and 5mg tablets
  • Clinical Information
    Genetic Alterations in Metastatic UCFGFR and TestingMechanism of ActionStudy DesignEfficacyDosing and AdministrationSafety
  • Support and Resources
    Support for BALVERSA®ResourcesHelp Your Patients
    Find an Eye Doctor
  • Prescribing Information
  • Medical Inquiries
  • Important Safety Information
  • Información de Prescripción
  • Register for Updates
  • For US Patients
  • Contact Us
  • Find a Representative from Johnson & Johnson
Week 0

Permission Required

  1. Home
  2. Permission Required

Sorry, you don’t have permission to access this page.

Please check the URL or go to the homepage.

Back to top